Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 326 clinical trials
None
Relationships Among Inflammation Physical and Mental Health in Subjects With Chronic Inflammatory Physical Diseases.

The prevalence of common mental disorders is high in patients with chronic inflammatory physical diseases(e.g., autoimmune or infectious diseases). The traditional explanatory causation model in which physical symptoms and related disability drive mental health problems is now called into question, and evidence has accumulated supporting more complex interactions whereby psychiatric …

antiviral therapy
HIV Infection
anxiety
HIV Vaccine
antiviral drugs
  • 0 views
  • 26 Nov, 2021
  • 1 location
None
Stopping Antiviral Treatment in Chronic Hepatitis B

complications. Many patients require long-term oral antiviral therapy since off-treatment sustained virological control can only be achieved in a minority of patients. It is uncommon for patients taking long

antiviral therapy
tenofovir
hepatitis
entecavir
cirrhosis
  • 0 views
  • 16 Oct, 2021
  • 1 location
None
Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus Relapse

The primary goal of hepatitis C virus (HCV) Direct Acting Antivirals (DAAs) is to achieve undetectable HCV RNA in the blood. A response that should be maintained for at least 12 weeks from completion of therapy. This is called sustained virological response (SVR) which corresponds to cure of HCV infection …

  • 0 views
  • 26 Jan, 2021
  • 1 location
None
Antiviral Drugs on the Treatment of SARS-CoV-2

Retrospective Non-Randomized Analytical Cohort Study of Completed SARS-CoV2 COVID19 Cases

  • 0 views
  • 14 Jun, 2021
  • 2 locations
None
Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors InteGrasE and Viral Protease.

The PRESTIGIO Registry is an Observational, prospective, multicentre study that includes patients, regularly followed by Italian Infectious Disease Centres, with HIV-1 infection and documented resistance to the 4 classes of antiretroviral drugs: nucleoside reverse transcriptase inhibitors (NRTI), non-nucleoside reverse transcriptase inhibitors (NNRTI), protease inhibitors (PI), and integrase inhibitors (INSTI). Main …

  • 0 views
  • 23 Jan, 2021
  • 1 location
None
HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy

years, several studies have indicated the HIV/HCV-coinfected patients had high risks of reinfection following successful antiviral treatment. The risk of HCV reinfection was reported to be 24.6% among

  • 0 views
  • 05 Mar, 2021
  • 7 locations
None
HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS Function

use disorder (AUD), before and after direct-acting antiviral (DAA) therapy [a new treatment for chronic infection with the hepatitis C virus (HCV)]. Demographically-matched comparison groups of

antiviral therapy
chronic infection
alcohol abuse
drug abuse
antiviral drugs
  • 4 views
  • 04 Sep, 2021
  • 1 location
None
AntiCMV mol cules Monitoring in Real-life in Stem Cell Recipients

Cytomegalovirus (CMV) is a ubiquitous herpesvirus that represent a major cause of morbidity in haematopoietic stem cell transplants (HSCT) recipients, mostly through reactivation of the recipient's virus. If left untreated, 40 to 80% of patients will develop CMV infection, leading to CMV disease in 30 to 35 % patients, and …

  • 0 views
  • 27 Jan, 2021
  • 1 location
None
Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in Germany

This is a prospective, non-interventional, multi-center study, in subjects with clinical indication of Human Immunodeficiency Virus (HIV)-1 infection. The aim of the study is to generate the real world evidence for the use of DTG+3TC in routine clinical care in Germany to supplement data obtained from controlled clinical trials. Approximately, …

HIV Vaccine
hiv-1 infection
immunodeficiency
antiviral drugs
lamivudine
  • 3 views
  • 25 Jan, 2021
  • 11 locations
None
A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients

-associated mortality. Liver diseases associated with HBV are affected by the antiviral drugs used for HIV infection (toxic side effects), the current immune function in the patient, by improvements

hepatitis
antiviral drugs
tenofovir
immunodeficiency
  • 6 views
  • 07 Nov, 2020
  • 1 location